Respiratory Viruses: New Treatment Options and Other Issues
The session on respiratory viruses will update the audience on promising treatment modalities for RSV and rhinoviruses, review the impact and management of influenza and other respiratory viruses in transplant recipients and discuss the genetic basis for adaptation of avian influenza viruses to humans.
Shingles Vaccine Coverage Low in Elderly Americans
Despite the approval and recommendation by the FDA of a shingles vaccine for adults over 50, only 16% of American seniors over 60 are vaccinated. Vaccinations are even lower for those aged 50-60. Only 4.3% have been vaccinated.
Melissa Johnson, Duke Univ. Med. Ctr., Durham, NC, United States
Poster Session 71, Paper B-493
Superbug Develops Resistance to Disinfectants
Acinetobacter, bacteria already infamous for developing resistance to most available antibiotics, also appear to develop resistance to disinfectants when exposed to them at sublethal concentrations.
Charalampos Tsoukalas, Nottingham Trent Univ., Nottingham, United Kingdom
Poster Session 72, Paper C1-505 (summary available)
New Compound Active Against C. difficile
A new compound, MBX 249A, exhibits potent activity against drug-resistant and toxigenic C. difficile in vitro and in multiple animal infection models.
Michelle Butler, Microbiotix, Inc., Worcester, MA, United States
Poster Session 82, Paper F-629
MRSA Infection Rates Lower in Previously Colonized
Patients who acquire MRSA after hospital admission are at higher risk of developing active MRSA infection than patients who were already colonized at admission.
Marie Roger, Univ. of Texas Hlth. Sci. Ctr., San Antonio, TX, United States
Poster Session 88, Paper K-687
New Arrival in Austria
|Contact: Garth Hogan|
American Society for Microbiology